Bio-Rad, HCA393, Belatacept antibody | AbD36935ia

Human Anti-Belatacept Antibody, clone AbD36935ia is an affinity-matured, non-inhibitory, anti-idiotypic antibody. It recognizes the drugs belatacept and abatacept, and their biosimilar products as well as cytotoxic T-lymphocyte antigen-4 (CTLA-4), also known as CD152. The antibody binds to free belatacept, abatacept and human CTLA4 and can be used to measure free belatacept, abatacept or their biosimilars in patient samples. Clone 36935ia is a monoclonal antibody with hIgG1 isotype and is suitable as a positive control or as detection antibody for Belatacept in a PK bridging ELISA. This Anti-Belatacept Antibody cross-reacts with the drug abatacept (Orencia). It is only 2 amino acids different from abatacept. LEA29Y-belatacept was constructed by two amino acid substitutions (L104E and A29Y) compared to abatacept that gave rise to slower dissociation rates for both CD86 and CD80. Belatacept (Nulojix) is a genetically engineered fusion protein which consists of the functional binding domain of modified human CTLA-4 and the Fc domain of human monoclonal immunoglobulin of the IgG1 subclass. The Fc part has the allotype IGHG1*05. Belatacept is indicated for prophylaxis of organ rejection in adult patients receiving a kidney transplant. It is to be used in combination with basiliximab induction, mycophenolate mofetil, and corticosteroids. View a summary of all anti-belatacept antibodies

Storage Information
This product is shipped at ambient temperature. It is recommended to aliquot and store at -20°C on receipt. When thawed, aliquot the sample as needed. Keep aliquots at 2-8°C for short term use (up to 4 weeks) and store the remaining aliquots at -20°C.
Avoid repeated freezing and thawing as this may denature the antibody. Storage in frost-free freezers is not recommended.